Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The full schedule uses 5660 injections, and each 70 mg GLOW vial contains 25 standard doses by mass
10.1056/NEJMoa2032183 67 WitkowskiM.WilkinsonL.WebbN.WeidsA.GlahD.VrazicH
For more information, read our full guide on switching from Wegovy (Ozempic) to Mounjaro
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Report of a case associated with high urinary excretion of vanilmandelic acid
Marx, N., Husain, M., Lehrke, M., Verma, S., & Sattar, N
